BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 1999

View Archived Issues

Sibia Neurosciences and Lilly enter collaboration for CNS disorders

Read More

Canadian university spins off new company to develop promising antibacterial agents

Read More

PathoGenesis signs European distribution agreements and launches TOBI in two new markets

Read More

NIAID-sponsored scientists on the way to developing a broad-spectrum staph vaccine

Read More

New perspectives for rFVIIa and rFVIIai

Read More

Remicade recommended for European approval by CPMP

Read More

Lamivudine to be launched in South Korea for hepatitis B

Read More

Phase II trial of York Medical's cancer vaccine cleared

Read More

Palatin Technologies prepares BLA for imaging agent

Read More

Additional phase II data suggest modifications for AVI BioPharma's cancer vaccine

Read More

Chinese scientists present new antiarrhythmic agent and effects on ischemia/reperfusion injury

Read More

Chinese scientists discover new MDR reversal agents during search for cardiovascular agents

Read More

New cholesterol-binding agent on the road to launch in Japan

Read More

Daiichi Pharmaceutical will market cevimeline in the U.S.

Read More

Chinese herbal remedy is safer and more effective than sildenafil in treating ED

Read More

Company Profile: ProtoMed

Read More

Carbapenems from Merck especially useful against resistant bacteria

Read More

Pfizer researchers present selective inhibitors of urokinase and their use

Read More

More on protein farnesyltransferase inhibitors in development at Merck

Read More

5-HT1A receptor agonists with good potency and selectivity designed at Pierre Fabre

Read More

Small study indicates therapeutic potential of sildenafil in women with sexual arousal disorders

Read More

Imidazole-based protein farnesyltransferase inhibitors for cancer

Read More

Novel class III antiarrhythmic agents synthesized at Merck

Read More

Novel matrix metalloproteinase inhibitor selectively inhibits rat osteosarcoma lung metastasis

Read More

Pharmacia & Upjohn's new treatment for ED in phase II testing; clinical results presented at AUA

Read More

Radiolabeled somatostatin analogue with potential for PET imaging and targeted radiotherapy

Read More

CGRP gene transfer successful and effective in rat model of pulmonary hypertension

Read More

Plant-derived compounds significantly reduce BP in hypertensive patients, SHRs

Read More

Hughes Institute publishes findings on anti-HIV agent active against resistant virus strains

Read More

Resubmission of ProMem NDA announced by Bayer

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing